• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Internet

National AI Team Fails at ‘Point Allocation Design’… The Paradox of AAII’s No. 1 Motif Being Eliminated [Kim Hyun-ah’s “Reading the IT World”]

My first thought upon seeing the results of the second evaluation of the “Dokpa-mo” (Proprietary AI Foundation Model) was, “Is this really right?”This is because Motif Technologies—which had ranked fi…
  • 2026-08-18 16:44:45
  • Kim Hyun-ah
Technology

ILDONG PHARM Group’s AIMS Establishes Support System for New Antimicrobial Drug Development… Resolving Development Bottlenecks

#AIMS BioScience (AIMS), a new drug development strategy consulting firm affiliated with ILDONG PHARM Group, announced on the 18th that it has been selected as the implementing agency for the “Plannin…
  • 2026-08-18 16:34:02
  • NA EUN-KYUNG
Internet

[Exclusive] Second Round of Dokpamo: Upstage, SKT, and LG Corp.… Reasons for Motif’s Elimination from AAII Top Spot

Ryu Je-myeong, Second Vice Minister of Science and ICT, is seen walking toward the podium on the morning of the 18th at the Seoul Government Complex to announce the results of the second-stage evaluat…
  • 2026-08-18 16:10:49
  • Han Kwangbeom
Internet

SKT Passes Second Round of Dokpamo: “A.X K2 to Expand Across Industries… We Will Create Outcomes That Benefit the Domestic AI Ecosystem”

SKTelecom(017670)has passed the second round of evaluation for the Reader AI Foundation Model (DOKPAMO) and has been selected as one of the final three elite teams. The company plans to focus on expan…
  • 2026-08-18 14:05:52
  • Kim Hyun-ah
Internet

Top AAII Motif Eliminated—Why Did LG Corp. Survive?…Dopamo Shifts to ‘Frontier AI’ [News+]

An unexpected outcome emerged in the second round of evaluations for the Ministry of Science and ICT’s Independent AI Foundation Model Project (DOKPAMO).While Motif Technologies—which had ranked first…
  • 2026-08-18 13:34:47
  • Kim Hyun-ah
Internet

Reason for AAII No. 1 Motif’s Elimination: ‘Usability Evaluation’… National AI Initiative Linked to Frontier Project [Q&A]

The Ministry of Science and ICT cited the “usability and applicability evaluation” as the reason for Motif Technologies’ elimination from the second round of evaluations for the Independent AI Foundat…
  • 2026-08-18 12:36:44
  • Kim Hyun-ah
Internet

National AI Team Qualifies... LG Corp. AI Research Institute Director Lim Woo-hyung: “We’ll Compete with Global AI in the Same Weight Class… and Continue to Take on the Challenge”

Lim Woo-hyung, Co-Director of the LG Corp. AI Research Institute, stated, “It is difficult to narrow the technological gap with global Big Tech using only small models,” adding, “We will continue to t…
  • 2026-08-18 11:12:46
  • Kim Hyun-ah
Technology

MEDIPOST CO., LTD. Signs CDMO Agreement with Q-Sistem for Breast Tissue Cell Culture Medium… to Support Mass Production

Stem cell therapy developer MEDIPOST CO., LTD.(078160)announced on the 18th that it has signed a contract for the contract development and manufacturing (CDMO) of “hiPSC-based mammary gland cell cultu…
  • 2026-08-18 11:11:02
  • NA EUN-KYUNG
Technology

DuChemBio Co, LTD Reports Record-High Second-Quarter Revenue… Growth Driven by Diagnostic Tests for Alzheimer’s, Parkinson’s, and Prostate Cancer

DuChemBio Co.,LTD.(176750), a company specializing in radiopharmaceuticals, announced on the 18th that it recorded sales of 20.9 billion won and operating profit of 3.2 billion won in the first half o…
  • 2026-08-18 11:07:01
  • NA EUN-KYUNG
Internet

Kakao’s Lightweight Language Model ‘Kanana-2’ Outperforms Global Models in Safety Assessment

Kakao(035720)’s lightweight language model (SLM) “Kanana-2” series scored highly in a safety evaluation comparing it to global open-source models of similar scale.Kakao announced on the 18th that it h…
  • 2026-08-18 10:44:27
  • Kim Hyun-ah
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English